Patents by Inventor Michael Fontaine

Michael Fontaine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7273930
    Abstract: The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S. iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: September 25, 2007
    Assignee: The University of Saskatchewan
    Inventors: Alexandra J. Bolton, Jose Perez-Casal, Michael Fontaine, Andrew A. Potter
  • Patent number: 7258992
    Abstract: The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysgalactiae GapC protein in addition to unique amino acid sequences from the Streptococcus parauberis and Streptococcus agalactiae GapC proteins, is described. Also described is the use of Gap4 chimeric GapC protein in vaccine compositions to prevent or treat streptococcal infections in general and mastitis in particular.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: August 21, 2007
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine
  • Patent number: 6936259
    Abstract: The CAMP factor gene of Streptococcus uberis (S. uberis) is described, as well as the recombinant production of CAMP factor therefrom. Also disclosed are chimeric CAMP factor constructs, including CAMP factor epitopes from more than one bacterial species. The CAMP factors and chimeras including the same can be used in immunogenic compositions for the prevention and treatment of bacterial infections.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: August 30, 2005
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine, Xinming Song
  • Publication number: 20050142615
    Abstract: The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysgalactiae GapC protein in addition to unique amino acid sequences from the Streptococcus parauberis and Streptococcus agalactiae GapC proteins, is described. Also described is the use of Gap4 chimeric GapC protein in vaccine compositions to prevent or treat streptococcal infections in general and mastitis in particular.
    Type: Application
    Filed: February 25, 2005
    Publication date: June 30, 2005
    Applicant: University of Saskatchewan
    Inventors: Andrew Potter, Jose Perez-Casal, Michael Fontaine
  • Publication number: 20050089529
    Abstract: The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S. iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.
    Type: Application
    Filed: December 6, 2004
    Publication date: April 28, 2005
    Inventors: Alexandra Bolton, Jose Perez-Casal, Michael Fontaine, Andrew Potter
  • Patent number: 6875853
    Abstract: The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysgalactiae GapC protein in addition to unique amino acid sequences from the Streptococcus parauberis and Streptococcus agalactiae GapC proteins, is described. Also described is the use of Gap4 chimeric GapC protein in vaccine compositions to prevent or treat streptococcal infections in general and mastitis in particular.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: April 5, 2005
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine
  • Patent number: 6866855
    Abstract: The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S. iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: March 15, 2005
    Assignee: University of Saskatchewan
    Inventors: Alexandra J. Bolton, Jose Perez-Casal, Michael Fontaine, Andrew A. Potter
  • Patent number: 6833134
    Abstract: The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S. iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: December 21, 2004
    Assignee: University of Saskacthewan
    Inventors: Alexandra J. Bolton, Jose Perez-Casal, Michael Fontaine, Andrew A. Potter
  • Publication number: 20040219639
    Abstract: The CAMP factor gene of Streptococcus uberis (S. uberis) is described, as well as the recombinant production of CAMP factor therefrom. Also disclosed are chimeric CAMP factor constructs, including CAMP factor epitopes from more than one bacterial species. The CAMP factors and chimeras including the same can be used in immunogenic compositions for the prevention and treatment of bacterial infections.
    Type: Application
    Filed: June 8, 2004
    Publication date: November 4, 2004
    Applicant: University of Saskatchewan
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine, Xinming Song
  • Publication number: 20040062774
    Abstract: The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysgalactiae GapC protein in addition to unique amino acid sequences from the Streptococcus parauberis and Streptococcus agalactiae GapC proteins, is described. Also described is the use of Gap4 chimeric GapC protein in vaccine compositions to prevent or treat streptococcal infections in general and mastitis in particular.
    Type: Application
    Filed: August 27, 2003
    Publication date: April 1, 2004
    Applicant: University of Saskatchewan
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine
  • Patent number: 6660270
    Abstract: The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysgalactiae GapC protein in addition to unique amino acid sequences from the Streptococcus parauberisand Streptococcus agalactiae GapC proteins, is described. Also described is the use of Gap4 chimeric GapC protein in vaccine compositions to prevent or treat streptococcal infections in general and mastitis in particular.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: December 9, 2003
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine
  • Publication number: 20030165524
    Abstract: The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S. iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.
    Type: Application
    Filed: April 26, 2002
    Publication date: September 4, 2003
    Inventors: Alexandra J. Bolton, Jose Perez-Casal, Michael Fontaine, Andrew A. Potter
  • Publication number: 20030082781
    Abstract: The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S. iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.
    Type: Application
    Filed: June 11, 2001
    Publication date: May 1, 2003
    Inventors: Alexandra J. Bolton, Jose Perez-Casal, Michael Fontaine, Andrew A. Potter
  • Publication number: 20030072765
    Abstract: The CAMP factor gene of Streptococcus uberis (S. uberis) is described, as well as the recombinant production of CAMP factor therefrom. Also disclosed are chimeric CAMP factor constructs, including CAMP factor epitopes from more than one bacterial species. The CAMP factors and chimeras including the same can be used in immunogenic compositions for the prevention and treatment of bacterial infections.
    Type: Application
    Filed: April 26, 2002
    Publication date: April 17, 2003
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine, Xinming Song
  • Publication number: 20020044928
    Abstract: The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysga/actiae GapC protein in addition to unique amino acid sequences from the Streptococcus parauberisand Streptococcus agalactiae GapC proteins, is described. Also described is the use of Gap4 chimeric GapC protein in vaccine compositions to prevent or treat streptococcal infections in general and mastitis in particular.
    Type: Application
    Filed: June 11, 2001
    Publication date: April 18, 2002
    Inventors: Andrew A. Potter, Jose Perez-Casal, Michael Fontaine